The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies

BMC Veterinary Research
A D MeierM N Sillence

Abstract

A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of withdrawal. Twenty-four insulin dysregulated ponies were selected, based on their hyper-responsiveness to a diet challenge meal containing 3.8 g non-structural carbohydrates (NSC)/kg bodyweight (BW). Ponies with serum insulin > 90 μIU/mL either 2 or 4 h after feeding were enrolled, and randomly allocated to receive either velagliflozin (0.3 mg/kg BW orally once daily, n = 12), or a placebo (n = 10-12) for 16 wk. The subjects were fed 7.5 g NSC/kg BW/day to maintain a fat body condition. Safety was assessed through daily monitoring, veterinary examination, and the measurement of fasting blood glucose, biochemistry and haematology. Efficacy at reducing post-prandial hyperinsulinemia was assessed using a diet challenge every 8 wk. during treatment and 4 wk. after withdrawal. Velagliflozin was well accepted by all subjects and caused no adverse effects or hypoglycaemia. Post-prandial serum insulin (insulin Cmax) did not change significantly in the c...Continue Reading

References

Oct 31, 2002·Equine Veterinary Journal. Supplement·D M PowellB P Fitzgerald
Jul 6, 2005·The Veterinary Journal·Charles F KearnsKaryn Malinowski
Nov 3, 2005·American Journal of Veterinary Research·Hugo EilerKellie A Fecteau
May 9, 2006·Journal of the American Veterinary Medical Association·Kibby H TreiberW Burton Staniar
Jun 15, 2006·The Journal of Nutrition·Patricia HarrisAnnette Longland
Aug 28, 2007·The Veterinary Journal·Katie E AsplinCatherine M McGowan
Nov 18, 2008·Journal of Animal Physiology and Animal Nutrition·S Van WeyenbergG P J Janssens
Feb 17, 2010·Equine Veterinary Journal·M A de LaatC C Pollitt
Apr 14, 2010·Journal of Veterinary Internal Medicine·N FrankUNKNOWN American College of Veterinary Internal Medicine
Sep 17, 2013·Equine Veterinary Journal·N Frank, E M Tadros
Jun 15, 2014·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Heidi E BanseDianne McFarlane
Nov 27, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay Kalra
Mar 27, 2015·Equine Veterinary Journal·R A MorganC M McGowan
Jan 1, 2014·Clinical Diabetes : a Publication of the American Diabetes Association·Edward C Chao
Nov 5, 2015·American Journal of Physiology. Endocrinology and Metabolism·M A de LaatM N Sillence
Mar 26, 2016·Journal of Veterinary Internal Medicine·L K DunbarT A Burns
Sep 11, 2016·BMC Veterinary Research·T WarnkenK Feige
Sep 19, 2016·Journal of Veterinary Internal Medicine·M A de LaatC C Pollitt
May 26, 2017·Equine Veterinary Journal·F R Bertin, M A de Laat
Feb 7, 2018·PeerJ·Murad H KhederMelody A de Laat
Feb 13, 2018·The Veterinary Journal·J C Patterson-KaneC M McGowan

❮ Previous
Next ❯

Citations

Aug 14, 2019·Expert Opinion on Investigational Drugs·Ernest AdeghateErnest A Adeghate

❮ Previous
Next ❯

Software Mentioned

Prism
Sigmaplot

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.